BENEVICH ERIC Insider Trades

Insider Trading History

Track insider trading activity for BENEVICH ERIC. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Commercial Officer
Holding Value $9.55M 67,297 shares
Last Trade
Sep 11, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$529k 3,386 shares
$156.22
$141.84
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Commercial Officer
Holding Value $10M 70,683 shares
Last Trade
Sep 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$980k 6,275 shares
$156.15
$141.84
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Commercial Officer
Holding Value $9.44M 66,562 shares
Last Trade
Sep 09, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$496k 3,194 shares
$155.14
$141.84
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Commercial Officer
Holding Value $9.14M 64,408 shares
Last Trade
Sep 09, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$333k 2,154 shares
$154.61
$141.84
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Sep 09, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$496k 3,194 shares
$155.14
$141.84
Atyr Pharma
Atyr Pharma ATYR
Director
Holding Value $15.2k 50,000 shares
Last Trade
May 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.5k 50,000 shares
$0.95
$0.30
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Commercial Officer
Holding Value $7.88M 55,540 shares
Last Trade
Feb 13, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$140k 1,124 shares
$124.12
$141.84
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Commercial Officer
Holding Value $8.04M 56,664 shares
Last Trade
Feb 13, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$258k 2,083 shares
$124.00
$141.84
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Commercial Officer
Holding Value $7.74M 54,581 shares
Last Trade
Feb 13, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$131k 1,058 shares
$124.12
$141.84
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Commercial Officer
Holding Value $5.15M 36,287 shares
Last Trade
Feb 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.5M 36,287 shares
$124.12
$141.84
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Commercial Officer
Holding Value $903k 6,365 shares
Last Trade
Feb 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$789k 6,365 shares
$124.00
$141.84
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Commercial Officer
Holding Value $295k 2,083 shares
Last Trade
Feb 13, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$258k 2,083 shares
$124.00
$141.84
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Commercial Officer
Holding Value $8.96M 63,190 shares
Last Trade
Feb 13, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.11M 8,963 shares
$124.12
$141.84
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Commercial Officer
Holding Value $7.89M 55,639 shares
Last Trade
Feb 13, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$243k 1,961 shares
$124.00
$141.84
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Commercial Officer
Holding Value $557k 3,924 shares
Last Trade
Feb 13, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$243k 1,961 shares
$124.00
$141.84
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Commercial Officer
Holding Value $10.2M 72,153 shares
Last Trade
Feb 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.06M 16,613 shares
$124.00
$141.84
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Commercial Officer
Holding Value $7.77M 54,760 shares
Last Trade
Feb 12, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$247k 2,005 shares
$123.10
$141.84
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Commercial Officer
Holding Value $853k 6,017 shares
Last Trade
Feb 12, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$247k 2,005 shares
$123.10
$141.84
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Commercial Officer
Holding Value $7.61M 53,678 shares
Last Trade
Feb 12, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$133k 1,082 shares
$123.10
$141.84
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Chief Commercial Officer
Holding Value $7.67M 54,047 shares
Last Trade
Jan 31, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$312k 2,294 shares
$136.06
$141.84

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up